Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian Cancer.

CONCLUSION: APMs have the potential to reduce costs of current FFS reimbursement via either a large reduction in imaging or a modest reduction in hospitalizations during treatment of ovarian cancer. PCOP is a reasonable payment structure for oncologists if the additional payments can provide the necessary resources to invest in improved coordination of care. PMID: 31613721 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31613721?dopt=Abstract

Source: JOP - October 14, 2019 Category: Gastroenterology Authors: Moss HA, Havrilesky LJ, Wang FF, Georgieva MV, Hendrix LH, Dinan MA Tags: J Oncol Pract Source Type: research